Close

HA-1

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

HMHA1 (Histocompatibility (Minor) HA-1) is a Protein Coding gene. Among its related pathways are Signaling by GPCR and Rho GTPase cycle. GO annotations related to this gene include GTPase activator activity. An important paralog of this gene is ARHGAP19.

Associated Disease
  • Hematological malignancies
  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-L039 Human anti-HMHA1 (VLHDDLLEA) T Cell Receptor, pMP71 Human VLHDDLLEA HLA-A2 retroviral vector   Add to Cart   Datasheet
TCR-L038Z Human anti-HA-1 (VLHDDLLEA) T cell receptor (Codon optimized and cysteine modified), pCDTCR1 Human VLHDDLLEA HLA-A2 Lentiviral   Add to Cart   Datasheet
TCR-C093Z Human anti-HA-1 T cell receptor (HA1.M7), pCDTCR1 Human HA1.M7 Human VLHDDLLEA HLA-A*0201 Lentiviral   Add to Cart   Datasheet
TCR-C094Z Human anti-HA-1  T cell receptor (KP7), pCDTCR1 Human KP7 Human VLHDDLLEA  HLA-A2 Lentiviral   Add to Cart   Datasheet
TCR-C095Z Human anti-HA-1  T cell receptor (3HA15), pCDTCR1 Human 3HA15 Human VLHDDLLEA HLA-A2 Lentiviral   Add to Cart   Datasheet
TCR-C096Z Human anti-HA-1  T cell receptor (5W38), pCDTCR1 Human 5W38 Human VLHDDLLEA HLA-A2 Lentiviral   Add to Cart   Datasheet
XS-0623-LX1 Anti-HA-1 (PD1/28-#1 TCR) T cell receptor, pCDTCR1 Vector Human #1 Human VLHDDLLEA HLA-A2 Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.